Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SNAP25 ELISA Kit (AC3302)
Cat.#: ASET-1891
Specifications
Description Human SNAP25 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SNAP25 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.023 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2204 Mouse Netrin 1 ELISA Kit (AC3615) Quantitative inquiry ASET-1989 Mouse FGF2 ELISA Kit (AC3400) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry ASET-2487 Mouse GDNF ELISA Kit (AC3898) Quantitative inquiry ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-2334 Mouse ACTH ELISA Kit (AC3745) Quantitative inquiry ASET-2417 Rat C Peptide ELISA Kit (AC3828) Quantitative inquiry ASET-1600 Human LAMP1 ELISA Kit (AC3011) Quantitative inquiry ASET-1416 Mouse beta Nerve Growth Factor ELISA Kit (AC2827) Quantitative inquiry ASET-1509 Rat PPAR gamma ELISA Kit (AC2920) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket